Results 11 to 20 of about 1,072,127 (359)
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
Journal of the American Medical Association (JAMA), 2020 This study examines the incidence of and risk factors for venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.
S. Bilaloglu +5 more
semanticscholar +1 more source
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization [PDF]
, 2020 Background: Requests to test for thrombophilia in the clinical context are often not evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large population of patients with different venous thromboembolic diseases ...
AMATO, FELICE +9 more
core +1 more source
Hepatology, 2020 An overview of the current understanding of bleeding and thrombosis in cirrhosis. An evidence-based justification for bleeding risk assessment in patients with cirrhosis prior to invasive procedures, including current concepts in preprocedural testing ...
P. Northup +7 more
semanticscholar +1 more source
Minor injuries as a risk factor for venous thrombosis [PDF]
, 2008 BACKGROUND: Injuries increase the risk of venous thrombosis. So far, most research has focused on major injuries that are accompanied by other risk factors for venous thrombosis, such as plaster casts and surgery.
Doggen, Carine J.M. +2 more
core +3 more sources
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
Circulation Research, 2020 The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the ensuing global pandemic has presented a health emergency of unprecedented magnitude. Recent clinical data has highlighted that coronavirus disease 2019 (COVID-19)
J. Mcfadyen, H. Stevens, K. Peter
semanticscholar +1 more source
Current perspective of venous thrombosis in the upper\ud extremity [PDF]
, 2008 Venous thrombosis of the upper extremity is a rare disease. Therefore, not as much is known about risk factors, treatment and the risk of recurrence as for venous thrombosis of the leg.
Doggen, C.J.M. +3 more
core +3 more sources
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Clinical and applied thrombosis/hemostasis, 2020 The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death
Wolfgang A. Miesbach, M. Makris
semanticscholar +1 more source
The incidence of portal vein thrombosis at liver transplantation [PDF]
, 1992 The incidence of portal vein thrombosis was examined in 885 patients who received orthotopic liver transplantations for various end‐stage liver diseases between 1989 and 1990. The thrombosis was classified into four grades.
Iwatsuki, S +3 more
core +1 more source
Intensive Care Medicine Experimental, 2018 Background Despite increasing ethical standards for conducting animal research, death is still often used as an endpoint in mouse sepsis studies. Recently, the Murine Sepsis Score (MSS), Mouse Clinical Assessment Score for Sepsis (M-CASS), and Mouse ...
Safiah H. C. Mai +7 more
doaj +1 more source
Annals of Internal Medicine, 2020 Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with substantial mortality.
S. Lax +8 more
semanticscholar +1 more source